Markets:

Overview

News

Currencies

International

Treasuries

Harrow, Inc. - Common Stock (NQ:HROW)

42.18 -0.82 (-1.91%)

Streaming Delayed Price Updated: 2:05 PM EDT, Jul 2, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Harrow, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Harrow Partners with Leading Healthcare Market Access Technology Platforms

January 03, 2024

From Harrow, Inc.

Via Business Wire

7 Short-Squeeze Stocks That Are Screaming for Speculation ↗

December 24, 2023

If you like to march to your own beat even against high pressure, these short-squeeze stocks could be right for you.

Via InvestorPlace

Harrow Completes Transfer of the TRIESENCE® New Drug Application

November 29, 2023

From Harrow, Inc.

Via Business Wire

Recap: Harrow Q3 Earnings ↗

November 13, 2023

Via Benzinga

Harrow Health's Earnings Outlook ↗

November 10, 2023

Via Benzinga

Harrow to Present at Two Investor Conferences in November

November 20, 2023

From Harrow, Inc.

Via Business Wire

12 Health Care Stocks Moving In Tuesday's After-Market Session ↗

November 14, 2023

Via Benzinga

Why Is Eyecare-Focused Harrow Health Stock Trading Lower Today? ↗

November 14, 2023

Harrow Health Inc (NASDAQ: HROW) reported Q3 revenues of $34.3 million, an increase of 50% Y/Y, missing the consensus of $37

Via Benzinga

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

November 14, 2023

Via Benzinga

Why INVO Bioscience Shares Are Trading Higher By Over 31%; Here Are 20 Stocks Moving Premarket ↗

November 14, 2023

INVO Bioscience, Inc. (NASDAQ: INVO) shares surged in pre-market trading after the company posted a narrower loss for the third quarter.

Via Benzinga

Why Beyond Air Shares Are Trading Lower By Around 37%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session ↗

November 14, 2023

Shares of Beyond Air, Inc. (NASDAQ: XAIR) dipped during Tuesday’s session following weak quarterly results.

Via Benzinga

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗

November 14, 2023

We're starting off Tuesday with a breakdown of all the biggest pre-market stock movers traders need to know about this morning!

Via InvestorPlace

Beauty Health Reports Downbeat Results, Joins Harrow, Fisker And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session ↗

November 14, 2023

U.S. stock futures traded higher this morning on Tuesday, with the Nasdaq futures gaining around 45 points this morning.

Via Benzinga

Home Depot, Beauty Health And 3 Stocks To Watch Heading Into Tuesday ↗

November 14, 2023

With U.S. stock futures trading higher this morning on Tuesday, some of the stocks that may grab investor focus today are as follows:

Via Benzinga

12 Health Care Stocks Moving In Monday's After-Market Session ↗

November 13, 2023

Via Benzinga

Harrow Announces Third Quarter 2023 Financial Results

November 13, 2023

From Harrow, Inc.

Via Business Wire

Earnings Scheduled For November 13, 2023 ↗

November 13, 2023

Companies Reporting Before The Bell • Sohu.com (NASDAQ:SOHU) is expected to report earnings for its third quarter. • Dixie Gr (NASDAQ:DXYN) is estimated to report earnings for its third quarter.

Via Benzinga

Harrow Will Release Third Quarter 2023 Financial Results on November 13, 2023

October 30, 2023

From Harrow, Inc.

Via Business Wire

Harrow Completes Transfer of NDAs and Launches FLAREX®, NATACYN®, TOBRADEX® ST, VERKAZIA®, and ZERVIATE® in the U.S.

October 24, 2023

From Harrow, Inc.

Via Business Wire

Harrow Health, Inc. Changes Corporate Name to Harrow, Inc.

September 29, 2023

From Harrow Health, Inc.

Via Business Wire

Melt Pharmaceuticals Announces Exclusive Development and License Agreement with Catalent for Its Zydis® Fast-Dissolve Technology for Use in MELT-300 for Needle- and Opioid-Free Procedural Sedation

September 26, 2023

From Melt Pharmaceuticals, Inc.

Via Business Wire

Harrow Announces Second Quarter 2023 Financial Results

August 09, 2023

From Harrow Health, Inc.

Via Business Wire

Harrow Launches VIGAMOX® in the U.S.

July 31, 2023

From Harrow Health, Inc.

Via Business Wire

Harrow to Announce Second Quarter 2023 Financial Results on August 9, 2023

July 26, 2023

From Harrow Health, Inc.

Via Business Wire

Nasdaq Moves Lower; US Crude Oil Inventories Decline Less Than Projected ↗

July 19, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite moving lower on Wednesday. The Dow traded up 0.31% to 35,058.78 while the NASDAQ fell 0.21% to 14,323.99. The S&P 500, also...

Via Benzinga

Why Amarin Shares Are Trading Lower By 23%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session ↗

July 19, 2023

Gainers Biodexa Pharmaceuticals Plc (NASDAQ: BDRX) rose 43% to $6.91.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Intraday Session ↗

July 19, 2023

Via Benzinga

Crude Oil Up 1%; M&T Bank Posts Upbeat Q2 Results ↗

July 19, 2023

U.S. stocks traded higher midway through trading, with the Nasdaq Composite gaining around 0.5% on Wednesday. The Dow traded up 0.53% to 35,137.16 while the NASDAQ rose 0.48% to 14,422.74. The S&P 500,...

Via Benzinga

Why Shares of Harrow Health Are Jumping Wednesday ↗

July 19, 2023

The company increased guidance, acquired a company, and had a stock sale.

Via The Motley Fool

Why Harrow Health Stock Is Trading Higher Today? ↗

July 19, 2023

Harrow Health Inc (NASDAQ: HROW) agreed to acquire the U.S. and Canadian commercial rights for Vevye (cyclosporine ophthalmic solution) 0.1%, a non‑preserved from Novaliq GmbH.

Via Benzinga

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.